In this issue:
MS disease activity and disability following discontinuation of natalizumab for pregnancy
Job satisfaction among MS physicians and nurses
MS patient's point of view on telemedicine
Subcortical volumes as early predictors of fatigue in MS
Spinal cord atrophy predicts progressive disease in relapsing MS
Effectiveness and safety of cladribine in MS
IFN treatment promotes SARS-CoV- 2 mRNA vaccine response in MS
Personality characteristics in MS and association with mood and cognition
Machine learning classifier to identify features of disability progression in MS
Switch from sequestering to anti-CD20 depleting treatment
Please login below to download this issue (PDF)